Brain implant to restore speech in locked-in syndrome and ALS
Tests an implanted brain-computer speech device in adults with locked-in syndrome.
Key facts
- Who runs it
- University Hospital, Grenoble
- Where
- Garches, Grenoble, Nîmes, and Saint-Etienne, FranceSee the 4 sites
- Trial code
- Registry title
- Evaluation of the Feasibility and Efficacy of a Chronic Brain-computer Interface for Speech Rehabilitation in Patients With Locked-in-syndrome (LIS)
- Status
- Not yet recruiting
- People taking part
- 3 people, planned
- Started
- 10 Oct 2026
- Expected to end
- 30 Sept 2031
- Type of study
- Interventional
- Treatments tested
- Chronic speech BCI
- Record updated
- 13 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with locked-in syndrome and severe speech problems, after a stroke or ALS, who will get a brain implant to help them speak.
- Age
- 18 to 65 years
- Sex
- Men and women
- Disease stage
- Locked-in syndrome with a severe speech disorder after a subcortical stroke or amyotrophic lateral sclerosis (ALS), in a stable clinical state, especially breathing
- Biomarker or test result
- Language areas of the brain still show signals on functional MRI
Main reasons for not taking part
- Severe cognitive disorders
- Deafness
- Continuous assisted ventilation
- Contraindication to intracranial surgery or to MRI, CT-scan or MEG
- Skull shape that does not fit a WIMAGINE implant on each side
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Male or female between 18 and 65 years old b. French speaking person c. Person in locked in syndrome with a severe speech disorder following either: i. A subcortical stroke ii. Amyotrophic Lateral Sclerosis. d. Person with stable clinical state (esp. regarding respiratory state) e. Person able to read on a screen (sufficient eye movement control) f. Negative plasma pregnancy test for women of childbearing potential* g. Highly effective or at least acceptable** contraception for women of childbearing potential
- Persistence of localizing signals of language function proven by functional MRI
- Person able to perform a simple BCI task with MEG j. Person with a neuropsychological profile evaluated by psychiatrist as compatible with sustain BCI training k. Informed consent to participate in the obtained using their usual means and code of communication (residual vocalizations, eye-blinking code, pictograms, eye tracking, alphabet chart, etc.), in the presence of their trusted person or curator who is accustomed to communicating with them using this means
- Person affiliated to the French social security system or beneficiary of such a system
Who cannot take part
- Contraindication to intracranial surgery
- Person with a skull shape incompatible with one WIMAGINE implant on each hemisphere
- Severe cognitive disorders assessed after a neuropsychological evaluation
- Functional impairment of language cortical areas on MRI
- Auditory evoked potential showing hearing impairment
- Patients with any of the following criteria cannot be included in this investigation:
- Deafness
- Continuous assisted ventilation
- Contra-indication to MRI (1.5T), CT-scan or their related contrast agent injection or MEG examinations
- Anatomical brain MRI showing structural abnormalities in the cortical areas of language
- Persons referred to in Articles L1125-7 of the Public Health Code and article 64 of MDR(corresponding to all protected persons: pregnant women, women in labor, breastfeeding mothers, minors, persons deprived of liberty by judicial or administrative decision
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Where in France
- Hôpital Raymond Poincaré GarchesGarches, FranceContact: Jonathan LEVY, DoctorNo longer taking part
- Centre hospitalier GrenobleGrenoble, FranceContact: Amina FONTANELLNo longer taking part
- Centre hospitalier NimesNîmes, FranceContact: Simon BERTRAND, DoctorNo longer taking part
- Centre hospitalier saint EtienneSaint-Etienne, FranceContact: Lydia OUJAMAA, DoctorNo longer taking part
About the trial
What the trial wants to find out
Eighteen million people worldwide are affected by speech disorders. Locked-in syndrome (LIS) represents the most extreme form of communication disability resulting from motor impairment. In France, the Association du Locked-In Syndrome (ALIS) reports approximately 500 individuals with LIS, most of whom live at home. The quality of life of people with LIS depends strongly on their ability to communicate, and speech synthesis is the mode of communication restoration most desired by individuals with LIS. Several surveys have shown that improving communication abilities in these individuals leads to a significant improvement in their quality of life as well as that of their caregivers.
Read full original descriptionShow less
Natural speech allows the production of an average of 150 words per minute. Non-invasive communication methods, whether based on residual motor function (eye-blink code) or on brain-machine or brain-computer interfaces (Brain-Computer Interface, BCI) using scalp electroencephalographic (EEG) signals, involve a high cognitive load and have low efficiency (spelling only a few letters per minute). Invasive BCIs for speech rehabilitation aim to overcome the limitations of non-invasive devices (cognitive overload and slow speech rate). The intention to act (the act of speaking) is predicted by an algorithm based on the direct decoding of neuronal activity from the sensorimotor cortex (the area where articulatory muscles are represented).
To date, studies testing speech rehabilitation BCIs in humans remain rare. A subdural electrocorticographic (ECoG) invasive BCI enabled speech decoding (words and sentences from a limited repertoire) for chronic use (2 years). Real-time control of an on-screen cursor allowing spelling of up to 90 letters per minute (equivalent to text messaging) has also been achieved using an intracortical invasive BCI (Utah Array). Very recently, up to 60 words per minute were produced using an intracortical invasive BCI (Utah Array) implanted in the ventral premotor cortex, although with a connector potentially contaminated by acoustic audio feedback. Furthermore, these devices still rely on transcutaneous connectors, which may be sources of infection and prevent routine daily-life use.
In summary, there is currently no fully implantable, wireless invasive "speech BCI" with real-time speech synthesis suitable for long-term home use. The present study will use an intracranial extradural invasive BCI combined with a speech synthesizer, with the aim of developing a communication tool suitable for everyday use. More specifically, the SpeechBCI protocol will propose two complementary BCI approaches in the same subject: a speech BCI (primary objective, BCI_PAROLE device) and a cursor BCI (secondary objective). Both BCIs will use the WIMAGINE intracranial epidural system, enabling ECoG signal acquisition with a very limited risk of infection and brain injury and providing signals that are more stable over time compared with intracortical or subdural ECoG devices that retain transcutaneous connectors. These systems will allow long-term and ecological use, as the WIMAGINE implant is wireless and offers excellent long-term signal stability. The WIMAGINE implant has already been successfully tested for controlling an exoskeleton in a tetraplegic subject (operational for over 6 years) and very recently for controlling walking in real-life conditions via a spinal cord stimulator in a paraplegic individual.
The BCI_PAROLE device will integrate a speech synthesizer providing real-time auditory feedback to the speaker. The BCI-CURSEUR device will allow the subject to control an on-screen cursor to access various communication functionalities (web access, emails, chats, etc.). This will provide a complementary communication solution to real-time speech production.
The hypothesis of this stydy is that the intention to speak (attempted speech) will be decoded by the BCI_PAROLE device in individuals with LIS because, as with limb paralysis, paralysis of articulatory and phonatory muscles does not prevent the corresponding cortical map from producing specific signals. Similarly, the BCI-CURSEUR device will decode the intention to move a cursor and perform actions on a computer screen.
Neuronal electrical signals will be recorded bilaterally from the ventral motor cortex (representation of lips, cheeks, tongue, palate, and larynx-the vocal tract) and from the dorsal part of the motor cortex (larynx and hand, the latter for controlling a two-degree-of-freedom cursor), using a total of 128 electrodes (64 on each cerebral hemisphere). The implant will be optimally positioned over speech motor areas using preoperative functional imaging in order to optimize speech decoding by the BCI_PAROLE device.
The group in the trial
- The subject serves as their own control in a crossover design.Treatment being tested
Chronic speech BCI
Treatment: Chronic speech BCI
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Evaluation of the Feasibility and Efficacy of a Chronic Brain-computer Interface for Speech Rehabilitation in Patients With Locked-in-syndrome (LIS)
- Plain-language title
- Brain implant to restore speech in locked-in syndrome and ALSGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Fit questions
- Built from NCT07698496, who can take part
- Record updated
- 13 July 2026